Early data suggest personalized neoantigen vaccines activate the immune system and sustain tumor control in some patients with kidney cancer.

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Smaller clinical trials of many neoantigen vaccines, including NCT03897881 for melanoma and NCT04161755 for pancreatic cancer, have shown promise for future use.

Advancing the battleground against cancer, this research meticulously details the development of neoantigen vaccines, a beacon of hope in personalized cancer therapy. These vaccines are custom ...

DUBLIN--(BUSINESS WIRE)--The "Global Neoantigen Cancer Vaccine Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global neoantigen cancer ...

Additional studies in lung cancer in combination with chemoimmunotherapy in metastatic disease, 78 glioblastoma after surgery and radiation, 79 and pancreatic cancer 80 suggested that peptide and RNA ...

The second study aimed to establish biomarker assays to identify patients for a first-in-human phase 1/2 trial (NCT051013560) of peptide vaccine LabVax 3(22)-23, a novel anti-tumor vaccine, alone ...

All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. Hector Pertuz – stock.adobe.com. Within three weeks of receiving the vaccine, patients showed ...

A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at ...

Advancing the battleground against cancer, this research meticulously details the development of neoantigen vaccines, a beacon of hope in personalized cancer therapy. These vaccines are custom ...